131 related articles for article (PubMed ID: 10978781)
1. Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line.
Gong Y; Wang Y; Chen F; Han J; Miao J; Shao N; Fang Z; Ou Yang R
Leuk Res; 2000 Sep; 24(9):769-74. PubMed ID: 10978781
[TBL] [Abstract][Full Text] [Related]
2. [Subcellular distribution of daunorubicin in the P-glycoprotein-mediated multidrug-resistant cell line K562/ADR].
Gong Y; Wang Y; Chen F
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):184-6. PubMed ID: 11783080
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Pgp- and MRP-mediated multidrug resistance in leukemia cell lines.
Gong YP; Liu T; Jia YQ; Qin L; Deng CQ; Yang RY
Int J Hematol; 2002 Feb; 75(2):154-60. PubMed ID: 11939261
[TBL] [Abstract][Full Text] [Related]
4. Altered intracellular distribution of daunorubicin in immature acute myeloid leukemia cells.
Lautier D; Bailly JD; Demur C; Herbert JM; Bousquet C; Laurent G
Int J Cancer; 1997 Apr; 71(2):292-9. PubMed ID: 9139856
[TBL] [Abstract][Full Text] [Related]
5. [Altered subcellular distribution of daunorubicin in the non-P-glycoprotein-mediated multidrug-resistant cell line HL-60/ADR].
Gong Y; Wang Y; Chen F; Han J; Shao N; Fang Z; Ouyang R
Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):309-11, 2. PubMed ID: 11876999
[TBL] [Abstract][Full Text] [Related]
6. Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.
Yang JY; Luo HY; Lin QY; Liu ZM; Yan LN; Lin P; Zhang J; Lei S
World J Gastroenterol; 2002 Aug; 8(4):644-9. PubMed ID: 12174371
[TBL] [Abstract][Full Text] [Related]
7. Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells.
Benderra Z; Morjani H; Trussardi A; Manfait M
Leukemia; 1998 Oct; 12(10):1539-44. PubMed ID: 9766497
[TBL] [Abstract][Full Text] [Related]
8. Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance associated protein and P-glycoprotein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Adv Exp Med Biol; 1999; 457():151-60. PubMed ID: 10500790
[TBL] [Abstract][Full Text] [Related]
9. Determination of intracellular organelles implicated in daunorubicin cytoplasmic sequestration in multidrug-resistant MCF-7 cells using fluorescence microscopy image analysis.
Bour-Dill C; Gramain MP; Merlin JL; Marchal S; Guillemin F
Cytometry; 2000 Jan; 39(1):16-25. PubMed ID: 10655559
[TBL] [Abstract][Full Text] [Related]
10. Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
Nagasawa K; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
Biol Pharm Bull; 1996 Jul; 19(7):971-6. PubMed ID: 8839972
[TBL] [Abstract][Full Text] [Related]
11. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes.
Hurwitz SJ; Terashima M; Mizunuma N; Slapak CA
Blood; 1997 May; 89(10):3745-54. PubMed ID: 9160680
[TBL] [Abstract][Full Text] [Related]
12. Monensin and verapamil do not alter intracellular localisation of daunorubicin in multidrug resistant human KB cells.
Wood DJ; Rumsby MG; Warr JR
Cancer Lett; 1996 Nov; 108(1):41-7. PubMed ID: 8950207
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms.
Urasaki Y; Ueda T; Yoshida A; Fukushima T; Takeuchi N; Tsuruo T; Nakamura T
Anticancer Res; 1996; 16(2):709-14. PubMed ID: 8687117
[TBL] [Abstract][Full Text] [Related]
14. Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Int J Oncol; 1998 Mar; 12(3):711-5. PubMed ID: 9472114
[TBL] [Abstract][Full Text] [Related]
15. [Restorative effect of quercetin on subcellular distribution of daunorubicin in multidrug resistant leukemia cell lines K562/ADM and HL-60/ADM].
Cai X; Chen FY; Han JY; Gu CH; Zhong H; Ouyang RR
Ai Zheng; 2004 Dec; 23(12):1611-5. PubMed ID: 15601547
[TBL] [Abstract][Full Text] [Related]
16. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy.
Gervasoni JE; Fields SZ; Krishna S; Baker MA; Rosado M; Thuraisamy K; Hindenburg AA; Taub RN
Cancer Res; 1991 Sep; 51(18):4955-63. PubMed ID: 1680024
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein.
Benderra Z; Trussardi A; Morjani H; Villa AM; Doglia SM; Manfait M
Eur J Cancer; 2000 Feb; 36(3):428-34. PubMed ID: 10708946
[TBL] [Abstract][Full Text] [Related]
18. An MDR-EGFP gene fusion allows for direct cellular localization, function and stability assessment of P-glycoprotein.
Pétriz J; Gottesman MM; Aran JM
Curr Drug Deliv; 2004 Jan; 1(1):43-56. PubMed ID: 16305369
[TBL] [Abstract][Full Text] [Related]
19. Modulation of daunorubicin cellular resistance by combination of P-glycoprotein blockers acting on drug efflux and intracellular drug sequestration in Golgi vesicles.
Merlin JL; Bour-Dill C; Marchal S; Ramacci C; Poullain MG; Giroux B
Cytometry; 2000 Sep; 41(1):62-72. PubMed ID: 10942898
[TBL] [Abstract][Full Text] [Related]
20. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.
Coley HM; Amos WB; Twentyman PR; Workman P
Br J Cancer; 1993 Jun; 67(6):1316-23. PubMed ID: 8099807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
